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Abstract
Purpose—To evaluate the psychosocial burden of adolescents with diabetes, determine the 
trajectory of psychosocial burden, and examine the interdependent relationships between 
psychosocial burden and glycemic control across the first six years of diabetes.
Methods—Data from SEARCH for Diabetes in Youth, an observational study of U.S. children 
diagnosed with diabetes before age 20 years, were collected during study visits conducted at 
baseline and then 12, 24, and 60 months after baseline. Blood was drawn, clinical and 
demographic information was collected, and psychosocial burden was evaluated using 
standardized depression and generic and diabetes-specific health-related quality of life (QOL) 
surveys.
Results—Among the 1,307 adolescents (mean age 14.1±2.5 years) with baseline data, 1,026 had 
type 1 diabetes and 281 had type 2 diabetes. For those with a 60-month follow-up visit, A1c 
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values rose 1.5% from baseline (type 1 - 7.7% to 9.3%; type 2 - 7.3% to 8.8%). Adolescents with 
type 2 diabetes reported more depression and poorer QOL than adolescents with type 1 diabetes. 
For each diabetes type, there were similar baseline risk factors for higher A1c values; longer 
diabetes duration, ethnic minority status, and declining diabetes QOL (p<0.05). However, youth 
with type 2 had higher A1c values with increasing generic QOL, an unexpected finding. Younger 
adolescents with type 1 diabetes had higher A1c values at study's end.
Conclusions—Significant deterioration in glycemic control marks the first six years of diabetes 
for adolescents. Psychosocial burden, particularly poor diabetes-specific QOL, is a contributor to 
suboptimal glycemic outcomes.
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Introduction
The psychosocial burden associated with pediatric diabetes is well-recognized, particularly 
among adolescents with type 1 diabetes. A recent meta-analysis comparing youth with type 
1 diabetes to youth without diabetes demonstrated elevated levels of psychosocial 
difficulties broadly, and specifically for depression (1). In one of the few long-term follow 
up studies of adolescents with type 1 diabetes, Kovacs and colleagues showed that nearly 
50% were diagnosed with a psychiatric disorder within ten years after diagnosis (2). The 
most common diagnosis was depression. In a host of other studies, depression has been 
linked to poorer diabetes management and control (3-6). Depression may interfere with 
diabetes management by reducing attention to and engagement with management activities 
such as checking blood glucose levels multiple times daily, adjusting the timing and dosing 
of insulin based on glucose levels, physical activity, and dietary intake, and constant 
vigilance for dangerous hypoglycemia. In addition, given this complex and demanding 
regimen, youth and their families are also charged with effectively solving unexpected or 
unpredicted problems that come up with management.
Less is known about the psychosocial burden of adolescents with type 2 diabetes. While the 
management regimen of youth with type 2 diabetes can be similar to the type 1 regimen, 
there is heightened focus on dietary intake, physical activity, and the potential addition of 
oral agents to lower blood glucose values. Youth with type 2 diabetes are not always on 
insulin. The available studies suggest that adolescents with type 2 diabetes have as much if 
not more psychosocial difficulties than adolescents with type 1 diabetes (7-8). Higher risk 
for psychosocial difficulties may be due to diabetes-specific factors or contextual factors 
associated with increased risk for conditions like depression, such as poorer health status, 
less family support, and fewer screening options for psychosocial burden and physical health 
(9-10). Beyond depression, quality of life (QOL) has also been examined as a marker of 
burden in adolescents with type 1 diabetes and type 2 diabetes. QOL is a broad construct 
that encompasses one's emotional, social, and academic/occupational functioning, as well as 
general well-being. This is often referred to as generic QOL. When QOL is considered 
within the context of a chronic disease such as diabetes, it is more specific and reflects 
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aspects of functioning in response to and considering diabetes management and impact on 
one's life. In general, both types of diabetes are associated with poorer QOL compared to 
peers without diabetes. However, adolescents with type 2 diabetes report poorer QOL than 
both peers without diabetes (11) and adolescents with type 1 diabetes (12). When 
adolescents with diabetes experience poorer health-related QOL, they are more likely to 
experience poorer diabetes management and control and depression (13-14).
While there is some understanding of the nature and correlates of psychosocial burden in 
youth with diabetes, the exact mechanisms that link psychosocial burden to diabetes 
management and control are not well characterized, particularly for youth with type 2 
diabetes. To address this, we conducted a longitudinal analysis of data collected as part of 
the SEARCH for Diabetes in Youth (SEARCH) study to: 1) evaluate the psychosocial 
burden (indicated by depression and a broader measure of health-related QOL) of youth with 
diabetes (type 1 or type 2 diabetes), 2) determine the patterns of psychosocial burden across 
the early stages of the disease course, and 3) examine the interdependent relationships 
between psychosocial burden and glycemic control over time.
Methods
SEARCH is an observational longitudinal study of youth with diabetes diagnosed before the 
age of 20 years of age in the United States. SEARCH participants are drawn from four 
geographically defined populations in Ohio, Washington, South Carolina, and Colorado, 
health plan enrollees in Hawaii and California, and Indian Health Service beneficiaries from 
four American Indian populations in Arizona and New Mexico. Prior to protocol 
implementation, local Institutional Review Board approval was obtained for each center.
Once cases were ascertained and validated by the study sites and registered with the data 
coordinating center, the parent/guardian or study participants age 18 years and older were 
invited to complete a short survey by telephone, mail, or in person, which included questions 
about race and ethnicity, diabetes treatment and documentation of physician-diagnosed 
diabetes. In specific cohort years, those who completed the initial survey whose diabetes 
was not secondary to other conditions were invited to a baseline study visit where surveys 
were administered to obtain clinical and demographic information as well as psychosocial 
burden. At the start of the study visit, participants 18 years and older and parents of youth 
under age 18 provided written informed consent for participation; youth less than 18 years 
provided assent (where applicable). In addition, a physical examination was completed to 
measure systolic and diastolic blood pressure, height, weight, and waist circumference. A 
blood sample was collected by venipuncture. Participants whose diabetes was incident in 
2002 through 2005 and who completed a baseline study visit were invited to return for 
follow-up visits at approximately 12, 24, and 60 months after their baseline visit. In this 
study, the mean diabetes duration at the baseline visit was 10.6 ± 6.7 months. Participants 
who missed a follow-up visit window remained eligible to complete the subsequent follow-
up visit(s) unless they refused future contact; this analysis includes participants who were 
≥10 years of age at the time of their baseline visit and completed at least one follow-up visit.
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Diabetes and Demographic Information—Data were collected at the time of the 
baseline and follow-up visits to characterize current diabetes treatment (type, dose, and 
delivery method of insulin or other medications), co-morbid medical and mental health 
conditions, proportion of diabetes care completed by the youth, and type of health insurance.
Depression—Symptoms of depression were measured among youth who were ≥ 10 years 
of age at their study visit with the Center for Epidemiologic Studies-Depression (CES-D) 
scale (15). The CES-D is a 20-item, widely used questionnaire that has been used to assess 
symptoms of depression in adults and adapted for use in children and adolescents (CES-D; 
16). We previously reported (7) that the internal consistency of the CES-D score for children 
10 to 11 years was not significantly different from those over 12 years, the minimum age in 
previous reports of its use. For each item, the respondent indicates the frequency that 
symptom occurs based on a four-point response set. Higher scores indicate more depressive 
symptoms. Epidemiologic data from adolescents indicate a score of 24 or higher is 
suggestive of depression and warrants further psychological evaluation (16).
Health-Related Quality of Life—The Pediatric Quality of Life Inventory (PedsQL) 
generic and diabetes modules (17) were administered at the baseline and follow-up visits. 
For all versions, items assess the degree of difficulty youth experience with different aspects 
of everyday living, including physical symptoms and emotional, social, and academic 
functioning (Generic Core) and treatment adherence and barriers, diabetes-related worries, 
and communication with others about diabetes (Diabetes Module). On both modules, scores 
range from 0-100 and higher PedsQL scores indicate better levels of functioning and QOL. 
The PedsQL modules have been validated in children ranging in age from 5 to 19 years. The 
age-specific forms used in this study were self-administered unless the child was unable to 
read the form adequately and needed staff assistance.
Glycemic Control—Blood samples obtained during the study visit were processed locally 
and shipped on ice for analysis to the Northwest Lipid Laboratory, University of 
Washington-Seattle. An ion exchange unit, Variant II, Bio-Rad Diagnostics (Hercules, CA), 
quantified the glycated hemoglobin (A1c).
Analytic Plan
Descriptives—Demographic and clinical characteristics were examined to determine 
means and standard deviations for continuous variables and frequencies and percentages for 
categorical variables. In addition, least squares mean scores of psychosocial burden 
measures (CES-D and generic and diabetes PedsQL scores) and A1c values and changes 
over time were examined from mixed linear models using only visit (baseline, 12, 24, or 60 
months), diabetes type, and their interaction as covariates.
Longitudinal Modeling—The multilevel models were initially run with type of diabetes 
as a covariate. Diabetes type was a significant predictor in all of the initial models. 
Considering that, along with documented differences in psychosocial burden by diabetes 
type in prior studies, it was determined that all models should be run stratified by diabetes 
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type. Each multilevel model was analyzed assuming a subject-specific random intercept and 
diabetes duration at the time of the visit as a random effect. Only available data at follow-up 
visits were used and no missing values were imputed. Both models for type 1 and type 2 
diabetes contained the same predictors of A1c, including baseline values of psychosocial 
burden (depression, generic and diabetes-specific QOL) and changes from baseline for each 
of the psychosocial measures. Change variables considered all time points; 12, 24, and 60 
month values. All models were adjusted for age at visit, race/ethnicity, and gender, and 
predictors were deemed statistically significant at the 0.05 level. These analyses were 
conducted using SAS/STAT® software, Version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
The mean (± SD) age of the 1,307 participants included in this analysis was 14.1 ± 2.5 years 
and the mean diabetes duration at the baseline visit was 10.6 ± 6.7 months (type 1 diabetes 
duration = 10.4 ± 6.5 months; type 2 diabetes duration = 11.4 ± 7.1 months). The sample 
was 50% female, 65% non-Hispanic white, and 78% of the youth had type 1 diabetes (Table 
1). The total number of participants completing each visit was: type 1 diabetes – 1,026 
(baseline), 540 (12 months), 520 (24 months), and 454 (60 months); type 2 diabetes – 281 
(baseline), 117 (12 months), 121 (24 months), and 102 (60 months). Participants excluded 
from these analyses for not having at least one follow-up visit tended to be older (p<0.01), 
had type 2 diabetes (p=0.02), were from families with lower household incomes (p=0.01) 
and were more likely to be insured by Medicare/Medicaid (p=0.02). They also had a higher 
A1c at baseline ( p<0.01) and reported lower diabetes-specific QOL on the PedsQL at 
baseline (p=0.03). There were no differences based on gender, race/ethnicity, family 
composition, CES-D scores, or generic PedsQL scores (p>0.05) at baseline.
Change Over Time
Table 2 shows means and SD for the CES-D, PedsQL-Generic, PedsQL-Diabetes, and A1c 
at the baseline visit and for each of the three follow-up visits. Table 2 also shows results of 
the mixed linear models of change from baseline to each of the follow-up visits to illustrate 
statistically significant change over time. The patterns were the same for youth with type 1 
and type 2 diabetes for mean A1c and showed a substantial deterioration over time. A1c 
values for youth with type 1 diabetes changed from a mean of 7.7% within the first year of 
diagnosis to 9.3% five years later. Similarly, in youth with type 2 diabetes A1c changed 
from 7.3% to 8.8%. Across the entire sample, A1c values rose nearly 1.5% during the first 
six years of diabetes.
Depression scores remained largely the same for youth with type 1 diabetes as they started at 
the mean of 9.7 and the mean was 9.6 five years later. The proportion of youth with type 1 
diabetes and highly elevated scores on the CES-D (defined as >24) remained fairly constant 
over time. Youth with type 2 diabetes started the study with more depressive symptoms than 
youth with type 1 diabetes as evidenced by mean scores nearly 5 points higher. Their mean 
at baseline was 14.3 and the mean decreased to 11.6 five years later, yet the proportion with 
highly elevated scores on the CES-D remained fairly constant over time. At all time points, 
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two to three times as many youth with type 2 diabetes had highly elevated scores compared 
to youth with type 1 diabetes.
QOL scores were more variable than depression scores, but consistently indicated that youth 
with type 2 diabetes have lower QOL scores than youth with type 1 diabetes. This was true 
across both the generic and diabetes-specific QOL modules. Youth with type 2 diabetes had 
generic QOL scores 4-8 points lower than youth with type 1 diabetes across time points. The 
difference in diabetes QOL was smaller; 1-5 points across time points. Across both modules 
and types of diabetes, QOL scores were relatively unchanged over time with the exception 
of the generic score for youth with type 2 diabetes which increased by approximately 4 
points over time. Of note, a recent paper (18) demonstrated that a minimal clinically 
important difference score on the PedsQL is around 5. This score means that a difference in 
a PedsQL score of 5 is clinically significant.
Longitudinal Modeling – Type 1 Diabetes
In the multilevel model predicting A1c at the 60-month study visit (Table 3), all baseline 
psychosocial burden measures, and demographic and clinical characteristics, were entered. 
In addition, change over time was included for each of the psychosocial burden measures. 
There were four variables that significantly (p<0.05) predicted higher A1c at 60 months 
post-baseline: younger age at baseline (relative to older age), longer duration of diabetes at 
baseline (relative to more recent onset of diabetes), being Black/African-American (relative 
to White, non-Hispanic), and decreasing diabetes quality of life over time.
Longitudinal Modeling – Type 2 Diabetes
The framework for the model for youth with type 2 diabetes was the same as the type 1 
model as the same covariates and measures were included. Table 4 provides complete 
results and shows that five variables significantly (p<0.05) predicted A1 values at the 60-
month study visit: longer diabetes duration at baseline (relative to more recent onset of 
diabetes), being Black/African American or Hispanic (relative to White, non-Hispanic), 
declining diabetes quality of life, and interestingly, increasing generic quality of life.
Conclusions
Data from SEARCH study participants show that the first six years of diabetes are marked 
by significant deterioration in glycemic control. This is the first study to document the 
longitudinal trajectories of psychosocial burden and glycemic control in such a large sample 
of youth with type 1 diabetes or type 2 diabetes. Further, worsening glycemic control is 
predicted by sociodemographic variables evident at diagnosis and changing psychosocial 
burden over time. These findings were consistent for adolescents with type 1 diabetes and 
those with type 2 diabetes. However, there were some important differences by diabetes 
type.
Across time points, adolescents with type 2 diabetes reported more psychosocial burden. At 
baseline, adolescents with type 2 diabetes had more depressive symptoms and had poorer 
QOL than youth with type 1 diabetes. As a reference point, the QOL and depressive 
symptom scores are similar to past reports in youth with diabetes, but indicate more 
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psychosocial burden than normative samples on these measures (CES-D and PedsQL) (16, 
19). The scores for youth with type 2 diabetes are particularly elevated compared to the 
normative samples for each scale. Part of these differences may be attributable to 
sociodemographic characteristics that placed more youth with type 2 diabetes at risk for 
psychosocial burden. There are multiple studies linking fewer resources and less access to 
healthcare to higher risk for depression (9-10). Further there are potential sources of stress 
from stigma or discrimination (generally or specific to diabetes/health) that were not 
measured in this study. Comparisons between type 2 and type 1 diabetes reveal that the 
families with adolescents with type 2 were more than three times more likely to have a 
household income of less than $25,000. Further, nearly 80% of families with adolescents 
with type 1 diabetes had private insurance, yet less than 50% of youth with type 2 diabetes 
had private insurance. Although these differences likely do not explain all of the differences 
in psychosocial burden between adolescents with type 2 diabetes and those with type 1 
diabetes, they may be substantial contributors. Likewise, our findings suggest that these 
factors are important to consider when developing treatment plans early in the course of 
diabetes.
For adolescents with type 1 and type 2 diabetes, declining diabetes-specific QOL predicted 
higher A1c values at end of the follow-up period. The patterns of QOL scores revealed that 
the majority of adolescents hovered around the same level of diabetes QOL over time. There 
does not appear to be any point we measured that stands out as a critical inflection point 
where QOL changes substantially from baseline. However, for those youth who perceived 
worsening diabetes QOL, commonly seen as diabetes disrupting everyday life, social and 
academic areas, they were more likely to have higher A1c values at study's end. It may be 
that this declining QOL became a barrier to effective daily management of diabetes and 
resulted in deteriorating glycemic control. It may also be that with increasing independence 
and lessening parental involvement related to diabetes care (which is developmentally 
appropriate for the transition from adolescence to young adulthood), there was less attention 
to diabetes and its management. This suggests that more should be done to preserve QOL 
specific to diabetes early in the course of diabetes and build effective coping and problem 
solving skills. Results from de Wit and colleagues on QOL suggests that routine assessment 
of QOL and addressing needs often can promote better QOL and diabetes outcomes (20-21). 
The data from the current study highlight a need for these targeted interventions to preserve 
QOL in youth with both types of diabetes. Several of the most potent interventions for 
children and adolescents with diabetes target improved coping and problem-solving skills, 
with benefits on generic and diabetes-specific QOL (22-23). Targeting those skills early in 
the course of diabetes as well as frequently at follow-up clinic visits may preserve QOL.
Interestingly, generic QOL was not a contributing factor to deteriorating glycemic control 
among youth with type 1 diabetes. However, among youth with type 2 diabetes, 
improvement in generic QOL predicted higher A1c values. Although this finding runs 
counter to prior findings in this area, largely in type 1 diabetes, it may suggest that small 
sacrifices are made by these youth from a diabetes standpoint to enjoy a better all-around 
QOL. For example, the social, academic, and interpersonal demands of adolescence and 
young adulthood may be higher priorities and with that comes less attention to the daily 
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management of diabetes. This subsequently leads to poorer glycemic control. Future studies 
should investigate this further.
It was surprising that QOL (primarily diabetes-specific) was the only aspect of psychosocial 
burden that predicted long-term glycemic control as depression (and distress) has been 
shown to influence management and control at multiple points in the course of diabetes. 
However, it is possible that relatively stable depression scores were overshadowed by more 
change observed in QOL scores. Further, QOL takes broader psychosocial functioning into 
account and the QOL and depression scores are correlated. These factors likely contributed 
to a stronger effect from QOL compared to depression. Of note, depressive symptoms were 
higher in youth with type 2 diabetes and more met accepted clinical cutoffs suggestive of 
further evaluation of a diagnosis of depression. This suggests we need to pay even closer 
attention to the psychological need of youth with type 2 diabetes.
There are several limitations to this study. First, the sample that completed the long-term 
follow-up visit differed from the sample at baseline. The sociodemographic variables that 
differed indicate that individuals with fewer resources – individually and in the family – 
were less likely to come back for follow-up visits. In addition, youth with type 2 diabetes 
and those with indicators of poorer functioning at the start of diabetes (i.e., higher A1c and 
poorer diabetes-specific QOL) were less likely to come back for follow-up visits. We cannot 
determine if these youth would also have had a different, potentially worsening trajectory on 
psychosocial burden measures and A1c. Further, the sample size for youth with type 2 
diabetes was significantly smaller than the sample of youth with type 1 diabetes, limiting our 
ability to investigate subgroups and relationships in the sample of youth with type 2 
diabetes. Clearly, more should be done to engage and retain all youth, but special attention 
to those more likely not to return should be a high priority in future studies. Second, the 
spacing of visits allowed for examination of psychosocial burden at 1, 2, and 5 years after 
study entry. However, we cannot determine with this study design if significant changes in 
psychosocial burden or glycemic control occurred between our study visits. Thus, the results 
of this study offer a global look at the trajectories of these variables over the first six years 
of diabetes and subtle changes may have been missed. Related to that is our sole use of A1c 
as an indicator of a diabetes-specific health outcome. While this is the gold standard 
measure of glycemic control in diabetes, other indicators including episodes of severe 
hypoglycemia and measures of glycemic variability may have served to provide additional 
information on the health status of these youth. Finally, our conceptualization of 
psychosocial burden was inclusive of depressive/distress symptoms and a broad 
characterization of QOL. There are a number of other areas of psychosocial burden (e.g., 
anxiety, perceived burden from diabetes, self-efficacy) that if measured, would have 
provided a more comprehensive examination of the full psychosocial burden of youth with 
diabetes.
The results of this study indicate that psychosocial burden, particularly health-related QOL, 
is a contributor to glycemic outcomes early in the course of childhood diabetes. Perceived 
QOL matters in the first year of diagnosis as well as the degree it changes in the following 
five years. This argues for early intervention and prevention to maximize QOL for youth 
with diabetes, both type 1 and type 2. Further, youth with type 2 diabetes appear at even 
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greater risk than their type 1 counterparts, possibly because of other contextual variables 
unrelated to diabetes. Because of the highly specialized nature of type 1 care in the United 
States and the relatively recent increases in type 2 in youth, it is likely that the current model 
of diabetes care for youth is not ideal for youth with type 2 diabetes. Considering that much 
of type 2 care in adults is provided in primary care clinics, models of care (and preservation 
of QOL) for youth with type 2 diabetes may require more focus on alternative clinics than 
tertiary care centers. Community-based programs may represent a better approach to 
reaching youth with type 2 diabetes and implementing health and behavior change programs 
that can be sustained. In addition to the emerging guidelines and evidence on depression 
screening in pediatric diabetes, QOL appears to be a critical area of psychosocial burden to 
screen for and address in youth with diabetes.
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Table 1
Baseline Characteristics of the Study Sample of Youth ≥ 10 Years at Baseline with at Least One Follow-Up 
Visit: The SEARCH for Diabetes in Youth Study
Type 1 Diabetes (n=1026) Type 2 Diabetes (n=281)
Characteristic Mean or Frequency SD or % Mean or Frequency SD or %
Age (years) 13.7 2.5 15.4 2.4
Diabetes duration (months) at baseline 10.4 6.5 11.4 7.1
Gender (percent male) 547 53.3 108 38.4
Race/ethnicity
    Asian/Pacific Islander 16 1.6 7 2.5
    Black/African American 102 9.9 109 38.8
    Hispanic 114 11.1 65 23.1
    White, non-Hispanic 784 76.4 68 24.2
    Native American 4 0.4 29 10.3
    Other/unknown 6 0.6 3 1.1
Family composition
    1 parent household 318 31.2 142 50.7
    2 parent household 669 65.7 117 41.8
    Other 32 3.1 21 7.5
Health insurance
    None 20 2.0 11 3.9
    Other 20 2.0 15 5.4
    Medicaid/Medicare 169 16.6 111 39.6
    Private 808 79.4 143 51.1
Highest parental education
    Less than HS graduate 50 4.9 50 17.9
    HS graduate 151 14.8 90 32.3
    Some College 339 33.3 93 33.3
    College graduate (bachelors degree or more) 478 47.0 46 16.5
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Table 2
Psychosocial Measures Burden and A1c Over Time for the Study Sample of Youth ≥ 10 years at Baseline that 
had at least One Follow-Up Visit: The SEARCH for Diabetes in Youth Study
Study Visit
Baseline 12 Mos 24 Mos 60 Mos
Diabetes Type Measure Mean (SE) Mean (SE/%BL) Δ from 
BL (SE)
Mean (SE/%BL) Δ from 
BL (SE)
Mean (SE/%BL) Δ from BL 
(SE)
TYPE 1 N 1026 540 (57%) 520 (51%) 454 (44%)
CES-D score 9.7 (0.3) 9.5 (0.3) −0.2 (0.3) 9.2 (0.3) −0.5 (0.3) 9.6 (0.3) −0.1 (0.3)
PedsQL - Generic 82.7 (0.4) 82.6 (0.5) −0.1 (0.5) 82.7 (0.5) 0.0 (0.5) 82.8 (0.5) −0.2 (0.5)
PedsQL - Diabetes 76.3 (0.4) 76.3 (0.5) 0.0 (0.5) 75.4 (0.5) −0.9 (0.5) 73.8 (0.6)
−2.4 (0.5)
**







TYPE 2 N 281 117 (42%) 121 (43%) 102 (36%)
CES-D score 14.3 (0.5) 13.0 (0.7) −1.3 (0.7) 13.5 (0.7) −0.8 (0.7) 11.6 (0.7)
2.6 (0.7)
**
PedsQL - Generic 74.7 (0.8) 78.8 (1.0)
4.1 (1.0)
** 76.5 (1.0) 1.8 (1.0) 78.3 (1.1)
3.6 (1.1)
**
PedsQL - Diabetes 71.2 (0.8) 75.0 (1.1)
3.9 (1.1)
** 72.9 (1.1) 1.7 (1.1) 73.6 (1.2)
2.5 (1.2)
*







Estimates from a mixed linear model to control for within-person variability using least-squares means and standard errors for time estimates and 
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Table 3
Correlates of Hemoglobin A1c from the Multilevel Model for 1,026 Youth with Type 1 Diabetes: The 
SEARCH for Diabetes in Youth Study
Variable Estimate Standard Error P
Intercept 10.99 0.799 <.0001
Duration of diabetes, months 0.02 0.003 <.0001
CES-D baseline 0.01 0.01 0.1875
CES-D change 0.001 0.008 0.9162
PedsQL Generic baseline 0.002 0.008 0.8276
PedsQL Generic change 0.004 0.006 0.4952
PedsQL Diabetes baseline −0.003 0.007 0.6750
PedsQL Diabetes change −0.03 0.005 <.0001
Age, years −0.07 0.025 0.0055
Black/African-American (vs White, non-Hispanic) 1.15 0.205 <.0001
Hispanic (vs White, non-Hispanic) 0.37 0.198 0.0646
Other (vs White, non-Hispanic) 0.65 0.397 0.1013
Female (vs Male) −0.1377 0.122 0.2621
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Table 4
Correlates of Hemoglobin A1c from Multilevel Models for 281 Youth with Type 2 Diabetes: The SEARCH 
for Diabetes in Youth Study
Variable Estimate Standard Error P
Intercept 7.76 1.89 <.0001
Diabetes Duration (months) 0.03 0.009 0.0017
CES-D baseline 0.03 0.026 0.2497
CES-D change 0.007 0.018 0.6846
PedsQL Generic baseline 0.037 0.019 0.0562
PedsQL Generic change 0.043 0.016 0.0136
PedsQL Diabetes baseline −0.034 0.019 0.0809
PedsQL Diabetes change −0.045 0.015 0.0053
Age −0.134 0.085 0.1263
Black/African-American (vs White, non-Hispanic) 1.535 0.495 0.0046
Hispanic (vs White, non-Hispanic) 1.454 0.568 0.0166
Other (vs White, non-Hispanic) 0.918 0.664 0.1789
Female (vs Male) −0.706 0.403 0.0917
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